CGEN: Compugen Limited Net earnings per share (EPS TTM)

Compugen (CGEN) - corporate logo

Compugen Ltd. ensures development stability through the diversification of biosubstance suppliers. The GURU.Markets terminal provides the EPS trend for the last 12 months, where this metric equals 0.37, confirming the asset's resilience. High market confidence is driven by major licensing contracts, while management's strategy relies on advanced computational methods for target discovery in immuno-oncology.

CGEN Compugen Ltd. Net earnings per share for the last 12 months (07/04/2022 - 11/10/2026)

Summary analytical data breakdowns for Compugen Ltd (CGEN)

- share price and expert price forecast:
Stock Quotes Compugen Limited|CGEN - Fair Value Consensus
- market capitalization information:
Market Capitalization Compugen Ltd.|CGEN - Company Buyout Price
- business book valuation details:
Net Assets per Single Share Compugen|CGEN - Company Net Assets|Market Value to Book Value Ratio cgen.com|CGEN - Cumulative Company Assets
- issuer credit burden and liquidity indicators:
Total Debt to Equity Ratio Compugen Ltd.|CGEN - Long-Term Debt to Capital|Short-Term Debt to Equity Compugen Limited|CGEN - Company Aggregate Debt|Debt to Book Capitalization Ratio Compugen Ltd.|CGEN - Long-Term Debt|Company Current Liabilities Compugen|Quick Liquidity Indicator cgen.com
- earnings and multiples data:
CGEN - Profit After Payment of Taxes|Projected Future Earnings Compugen Ltd.|CGEN - Company Value to Net Income|Forward P/E Multiple Compugen Limited|CGEN - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Compugen Ltd.|CGEN - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Compugen|CGEN - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months cgen.com|CGEN - Earnings per share trend in current year|Expected earnings per share growth for next year Compugen Ltd.
Fundamental valuation:CGEN - cgen.com
Flagship merchandise of Compugen Limited

The efficiency of PVRIG antibody development and the monetization of its AI platform in the B2B sector determine the financial stability of Compugen Ltd. (CGEN). This indicator calculates the net profit allocated per share over a rolling year, allowing for an assessment of the real return on capital without distortions between reports. By analyzing the trend of earnings per share over the last 12 months, an investor can identify the growth stage or the risk of overpaying for the asset.

Main competitors

IBRX: Net earnings per share for the last 12 months|Earnings per share for the trailing year IMCR (immunocore.com)|JANX: Net earnings per share (EPS TTM)|RCUS - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Zymeworks Corp|Net earnings per share for the last 12 months Tango Therapeutics Corp (TNGX)|Earnings per share for the last twelve months Iovance Biotherapeutics (IOVA)|Net earnings per share for the last 12 months immatics.com IMTX|Xencor - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Compass Therapeutics Inc CMPX|REPL - Earnings per share for the last twelve months|LYEL (Lyell Pharma) - Earnings per share for the last 12 months|Innate Pharma S.A. (IPHA) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Pyxis Oncology (PYXS)|Net earnings per share for the last 12 months IOBT|STRO - Net earnings per share for the trailing year|Net earnings per share for the last 12 months INKT (MiNK)|Earnings per share for the last four quarters HOWL|Net earnings per share (EPS TTM) IMMX (Immix Biopharma)|Earnings per share for the trailing year ALXO|Cue Biopharma, Inc. - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months PDS Biotechnology|sonnetbio.com (SONN) - Earnings per share for the last twelve months|MAIA Bio - Earnings per share for the trailing year|LIMN (Liminatus Pharma) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Lava Tx|Earnings per share for the last twelve months NextCure (NXTC)|LPTX: Earnings per one share for the last 12 months|Intensity Therapeutics, Inc. - Net earnings per share for the last 12 months|Sensei Biotherapeutics Inc (SNSE) - Net earnings per one share for the last twelve months|Theriva Biologics, Inc. - Net earnings per share (EPS TTM)|Gritstone bio, Inc. (GRTS) - Net earnings per share for the last 12 months|Kineta (KA) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months NexImmune Inc (NEXI)|Earnings per share for the last twelve months Turnstone Biologics Corp|Net earnings per share for the last 12 months Vaccinex Inc (VCNX)|Earnings per share for the last twelve months Harpoon Therapeutics (HARP)